Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A look at the past to draw lessons for the future: how the case of an urgent ICU transfer taught us to always be ready with a plan B.
Brunelli L, Miotto E, Del Pin M, Celotto D, Moccia A, Borghi G, De Monte A, Macor C, Cocconi R, Lattuada L, Brusaferro S, Arnoldo L. Brunelli L, et al. Among authors: moccia a. Front Med (Lausanne). 2023 Nov 20;10:1253673. doi: 10.3389/fmed.2023.1253673. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38053617 Free PMC article.
Altered H3K4me3 profile at the TFAM promoter causes mitochondrial alterations in preadipocytes from first-degree relatives of type 2 diabetics.
Longo M, Zatterale F, Spinelli R, Naderi J, Parrillo L, Florese P, Nigro C, Leone A, Moccia A, Desiderio A, Raciti GA, Miele C, Smith U, Beguinot F. Longo M, et al. Among authors: moccia a. Clin Epigenetics. 2023 Sep 7;15(1):144. doi: 10.1186/s13148-023-01556-z. Clin Epigenetics. 2023. PMID: 37679776 Free PMC article.
De novo variants in GATAD2A in individuals with a neurodevelopmental disorder: GATAD2A-related neurodevelopmental disorder.
Werren EA, Guxholli A, Jones N, Wagner M, Hannibal I, Granadillo JL, Tyndall AV, Moccia A, Kuehl R, Levandoski KM, Day-Salvatore DL, Wheeler M; University of Washington Center for Mendelian Genomics; Chong JX, Bamshad MJ, Innes AM, Pierson TM, Mackay JP, Bielas SL, Martin DM. Werren EA, et al. Among authors: moccia a. HGG Adv. 2023 Apr 20;4(3):100198. doi: 10.1016/j.xhgg.2023.100198. eCollection 2023 Jul 13. HGG Adv. 2023. PMID: 37181331 Free PMC article.
Bio-Physics Approach to Urinary Incontinence Disabilities.
Prosperi L, Barassi G, Panunzio M, Pellegrino R, Marinucci C, Di Iulio A, Colombo A, Licameli M, Moccia A, Melchionna M. Prosperi L, et al. Among authors: moccia a. Int J Environ Res Public Health. 2022 Oct 2;19(19):12612. doi: 10.3390/ijerph191912612. Int J Environ Res Public Health. 2022. PMID: 36231912 Free PMC article.
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
Hitz F, Lang N, Mey U, Mingrone W, Moccia A, Taverna C, Novak U, Stenner F, Schmidt A, Mamot C, Fischer N, Putora PM. Hitz F, et al. Among authors: moccia a. Oncology. 2023;101(3):159-165. doi: 10.1159/000526360. Epub 2022 Sep 27. Oncology. 2023. PMID: 36103806 Free article.
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Stathis A, Mey U, Schär S, Hitz F, Pott C, Mach N, Krasniqi F, Novak U, Schmidt C, Hohloch K, Kienle DL, Hess D, Moccia AA, Unterhalt M, Eckhardt K, Hayoz S, Forestieri G, Rossi D, Dirnhofer S, Ceriani L, Sartori G, Bertoni F, Buske C, Zucca E, Hiddemann W. Stathis A, et al. Among authors: moccia aa. Blood Adv. 2022 Jul 12;6(13):3911-3920. doi: 10.1182/bloodadvances.2021006520. Blood Adv. 2022. PMID: 35537101 Free PMC article. Clinical Trial.
65 results